Molecular Docking on Kokosanolide A and C for Anticancer Activity Against Human Breast Cancer Cell MCF-7

5Citations
Citations of this article
22Readers
Mendeley users who have this article in their library.

Abstract

Kokosanolide A (1), from the seeds of Lansium domesticum Corr. cv Kokossan, has been shown strong cytotoxic activities (IC50 = 8.62 μg/mL) against MCF-7 breast cancer cells. The aim of this work was to study the molecular interactions of kokosanolid A and kokosanolid C with the Estrogen Receptor α (ERα) using computer aided drug design approaches. Molecular docking using Autodock Vina (open-source software PyRx 0.8) was employed to explore the modes of binding of kokosanolid A (1) and kokosanolid C (2) with ERα. Compound 1 and 2 showed strong bond-free energy (-8.8 kcal/mol and-8.7 kcal/mol) to ERα. These two compounds have molecular mechanism to inhibit ERα in breast cancer cells.

Cite

CITATION STYLE

APA

Purwani, S., Nahar, J., Zulfikar, Nurlelasari, & Mayanti, T. (2021). Molecular Docking on Kokosanolide A and C for Anticancer Activity Against Human Breast Cancer Cell MCF-7. Jurnal Kimia Valensi, 7(1), 52–57. https://doi.org/10.15408/jkv.v7i1.20534

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free